CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $261,000 | +16.0% | 112,157 | +41.3% | 0.01% | 0.0% |
Q4 2017 | $225,000 | -7.4% | 79,357 | -6.7% | 0.01% | -16.7% |
Q3 2017 | $243,000 | -37.2% | 85,079 | -20.8% | 0.01% | -33.3% |
Q1 2017 | $387,000 | -32.9% | 107,400 | -34.2% | 0.02% | -47.1% |
Q4 2016 | $577,000 | +815.9% | 163,100 | +938.9% | 0.03% | +70.0% |
Q3 2016 | $63,000 | -97.0% | 15,700 | -96.8% | 0.02% | -81.1% |
Q2 2016 | $2,123,000 | -38.4% | 483,807 | -46.9% | 0.11% | -31.2% |
Q1 2016 | $3,446,000 | +1283.9% | 911,825 | +10090.3% | 0.15% | +1611.1% |
Q1 2015 | $249,000 | -83.6% | 8,948 | -89.6% | 0.01% | -88.8% |
Q1 2014 | $1,518,000 | +94.6% | 85,939 | +166.6% | 0.08% | +95.1% |
Q4 2013 | $780,000 | -17.9% | 32,231 | -47.1% | 0.04% | +32.3% |
Q2 2013 | $950,000 | – | 60,893 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |